Global health policymakers, donors, and other stakeholders are navigating difficult, uncharted waters as compounding crises—from sudden funding cuts to new health threats posed by climate change to geopolitical instability—threaten to erase hard-won gains and leave the world more vulnerable to preventable illnesses and inequitable access to healthcare. Health systems are still recovering from the COVID-19 pandemic, and with the global health AI revolution in full-swing, decision makers must distinguish efficient use cases of new technologies and innovations from those that create redundancies or contribute to unethical health delivery.
Global health stakeholders collect and analyze data to better understand emerging challenges and where global health investments are most impactful. When that data is available and accessible to key decision makers at global, national, and subnational levels, they are better able to:
Detect problems early – Reliable data reveals disease outbreaks, inequities in care, or resource shortages before they escalate.
Allocate resources effectively – Health budgets are limited; data helps target interventions where they’ll have the greatest impact.
Measure progress – Accurate information shows whether programs are working, where they’re falling short, and how to adapt.
Build trust and accountability – Transparent, evidence-based decisions strengthen public confidence and donor support.
Drive innovation – Data uncovers patterns and needs that can inspire new treatments, policies, and delivery models.
However, a significant portion of that data is left out of the decision-making process – this is known as the knowledge-to-policy gap.